[1]赖璐华,李玉兰.营养风险筛查在住院2型糖尿病患者中的应用[J].医学信息,2021,34(01):46-48.[doi:10.3969/j.issn.1006-1959.2021.01.013]
　LAI Lu-hua,LI Yu-lan.Application of Nutritional Risk Screening in Hospitalized Patients with Type 2 Diabetes[J].Medical Information,2021,34(01):46-48.[doi:10.3969/j.issn.1006-1959.2021.01.013]
点击复制

营养风险筛查在住院2型糖尿病患者中的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年01期
页码:
46-48
栏目:
综述
出版日期:
2021-01-01

文章信息/Info

Title:
Application of Nutritional Risk Screening in Hospitalized Patients with Type 2 Diabetes
文章编号:
1006-1959（2021）01-0046-03
作者:
赖璐华; 李玉兰
（柳州市人民医院内分泌科，广西 柳州 545006）
Author(s):
LAI Lu-hua; LI Yu-lan
(Department of Endocrinology,Liuzhou People’s Hospital,Liuzhou 545006,Guangxi,China)
关键词:
营养风险; 2型糖尿病; 营养风险筛查2002; 住院
Keywords:
Nutritional risk; Type 2 diabetes; Nutritional risk screening 2002; Hospitalization
分类号:
R473.5
DOI:
10.3969/j.issn.1006-1959.2021.01.013
文献标志码:
A
摘要:
营养风险筛查是发现患者营养问题的重要手段，也是判定其是否需要营养治疗的基本前提。通过发现患者的营养风险，可以预测患者的临床结局，明确患者通过临床营养支持获得的治疗效果。2型糖尿病患者往往被认为"营养过剩"，其存在的营养风险在临床工作中容易被医生忽视。本文将就在住院2型糖尿病患者中进行营养风险筛查的必要性、筛查工具的选择及营养风险筛查2002的应用等作一综述。
Abstract:
Nutrition risk screening is an important means to discover nutritional problems in patients, and it is also a basic prerequisite for determining whether they need nutritional treatment. By discovering the nutritional risk of the patient, the clinical outcome of the patient can be predicted, and the treatment effect obtained by the patient through clinical nutritional support can be clarified. Patients with type 2 diabetes are often considered "overnutrition", and their nutritional risks are easily ignored by doctors in clinical work. This article will review the necessity of nutritional risk screening in hospitalized patients with type 2 diabetes, the selection of screening tools, and the application of nutritional risk screening 2002.

参考文献/References:

[1]Cederholm T,Barazzoni R,Austin P,et al.ESPEN guidelines on definitions and terminology of clinical nutrition[J].Clin Nutr,2017,36(1):49-64. [2]中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):1-67. [3]中华医学会糖尿病学分会,中国医师协会营养医师专业委员会.中国糖尿病医学营养治疗指南(2013)[J].中华糖尿病杂志,2015,7(2):73-88. [4]Sauer AC,Gostes S,Malone A,et al.Prevalence of malnutrition risk and the impact of nutrition risk on hospital outcomes:results from nutritionDay in the U.S[J].J Parenter Enteral Nutr,2019,43(7):918-926. [5]张燕,王利仙,吕晓华,等.微型营养评估简表在老年慢性病住院患者营养筛查中的应用[J].中华老年多器官疾病杂志,2019,18(2):107-111. [6]Kondrup J,Allison SP,Elia M,et al.ESPEN guidelines for nutrition screening 2002[J].Clin Nutr,2003,22(4):415-421. [7]周锦,高娉,马宁,等.住院病人营养风险筛查及营养支持对临床结局影响的研究[J].肠外与肠内营养,2017,24(1):13-17. [8]Schuetz P,Fehr R,Baechli V,et al.Individualised nutritional support in medical inpatients at nutritional risk:a randomised clinical trial[J].Lancet,2019,393(10188):2312-2321. [9]刘璟瑜,何辉,李素芳,等.老年糖尿病并肺炎患者营养支持效果观察[J].现代临床医学,2018,44(1):16-18,21. [10]Zhu MW,Wei JM,Chen W,et al.Nutritional Risk and Nutritional Status at Admission and Discharge among Chinese Hospitalized Patients:A Prospective,Nationwide,Multicenter Study[J].J Am Coll Nutr,2017,36(5):357-363. [11] 车千红,赵晴,郭佳琦.内科常见疾病住院患者营养风险筛查分析评价[J].山东大学学报(医学版),2012,50(2):128-130,134. [12]蒋朱明,陈伟,朱赛楠,等.中国东、中、西部大城市三甲医院营养不良(不足)、营养风险发生率及营养支持应用状况调查[J].中国临床营养杂志,2008,16(6):335-377. [13]张玉鹏,章黎,黄迎春,等.中国住院病人营养不良及住院时问延长的危险因素分析[J].肠外与肠内营养,2020,27(3):136-142. [14]Raslan M,Gonzalez MC,Dias MC,et al.Comparison of nutritional risk screening tools for predicting clinical outcomes in hospitalized patients[J].Nutrition,2010,26(7-8):721-726. [15]Zhang XY,Zhang XL,Zhu YX,et al.Predictive value of nutritional risk screening 2002 and nini nutritional assessment short form in mortality in Chinese hospitalized geriatric patients[J].Clin Interv Aging,2020(15):441-449. [16]蒋聪,杨浩,陈伟,等.住院病人的营养不良风险筛查[J].肠外与肠内营养,20l6,23(3):158-161. [17]李惠萌,史文丽,马向丽.NRS2002和SGA在不同体质指数2型糖尿病患者中的应用研究[J].实用预防医学,2014,21(12):1525-1528. [18]刘晔,欧阳晓俊,蔡晓真,等.内科老年住院患者营养状况及其影响因素分析[J].中国临床保健杂志,2019,22(2):174-178., [19]潘素琼,陈晓,陆媚英,等.2型糖尿病住院患者456例营养风险筛查分析[J].广西医学,2016,38(5):681-683. [20]张德桂,张会,徐咏梅,等.营养风险筛查2002在住院糖尿病患者营养筛查中的应用[J].中国临床保健杂志,2015,18(5):538-539. [21]许美艳,尹键,石劢.糖尿病住院患者营养状况评价和分析[J].中国食物与营养,2014,20(4):84-87. [22]孔建华,张洁,滑莹莹,等.营养风险筛查在老年糖尿病肾病患者营养评估中的应用[J].中国临床保健杂志,2017,20(1):58-60. [23]吕坤英.老年糖尿病患者营养风险筛查及分析[J].中国继续医学教育,2020,12(12):93-95. [24]李红月,张小丽,张盼,等.急性心肌梗死合并糖尿病患者营养风险、应对方式与生活质量的关系及路径分析[J].中国老年学杂志,2018,38(13):3250-3253. [25]丁小敏,赵焕英,邢凤梅,等.脑卒中并发糖尿病患者营养风险筛查[J].中国康复理论与实践,2013,19(9):866-868.

相似文献/References:

[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
　HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in Patients with Type 2 Diabetes Mellitus[J].Medical Information,2018,31(01):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
　DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Medical Information,2018,31(01):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的 相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
　CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Medical Information,2018,31(01):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
　JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(01):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
　LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Medical Information,2018,31(01):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]郭云飞,王亚柱,刘 超,等.血浆致动脉硬化指数与冠心病合并2型糖尿病的相关性分析[J].医学信息,2022,35(09):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
　GUO Yun-fei,WANG Ya-zhu,LIU Chao,et al.Correlation Between Plasma Arteriosclerosis Index and Coronary Heart Disease Complicated with Type 2 Diabetes Mellitus[J].Medical Information,2022,35(01):108.[doi:10.3969/j.issn.1006-1959.2022.09.027]
[7]徐晨曦.达格列净联合DPP-4抑制剂与二甲双胍对血糖控制不佳2型糖尿病患者血糖及脂代谢的影响[J].医学信息,2022,35(09):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
　XU Chen-xi.Effects of Daglitazone Combined with DPP-4 Inhibitor and Metformin on Blood Glucose and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus with Poor Glycemic Control[J].Medical Information,2022,35(01):165.[doi:10.3969/j.issn.1006-1959.2022.09.042]
[8]余 佳.早期胰岛素强化治疗对初诊2型糖尿病患者血糖控制效果及颈动脉粥样硬化进展的影响[J].医学信息,2022,35(10):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
　YU Jia.Effect of Early Intensive Insulin Therapy on Blood Glucose Control and Progression of Carotid Atherosclerosis in Newly Diagnosed Type 2 Diabetic Mellitus Patients[J].Medical Information,2022,35(01):140.[doi:10.3969/j.issn.1006-1959.2022.10.034]
[9]张剑君.2型糖尿病参与血管衰老的机制[J].医学信息,2022,35(11):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
　ZHANG Jian-jun.The Mechanism of Type 2 Diabetes Mellitus in Vascular Aging[J].Medical Information,2022,35(01):37.[doi:10.3969/j.issn.1006-1959.2022.11.011]
[10]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行 健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
　LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Medical Information,2018,31(01):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
[11]赖璐华,李玉兰,黄秋菊,等.有营养风险的2型糖尿病周围神经病变患者的临床特征研究[J].医学信息,2022,35(17):120.[doi:10.3969/j.issn.1006-1959.2022.17.032]
　LAI Lu-hua,LI Yu-lan,HUANG Qiu-ju,et al.Clinical Characteristics of Type 2 Diabetic Peripheral Neuropathy Patients with Nutritional Risk[J].Medical Information,2022,35(01):120.[doi:10.3969/j.issn.1006-1959.2022.17.032]

更新日期/Last Update: 1900-01-01